Organon USA Inc. Newsletter
-
Organon Acquires Commercialized Biosimilar to ACTEMRA from Biogen
04 Apr 2025 21:14 GMT
Organon acquired regulatory and commercial … a key growth driver for Organon, and this acquisition complements our … immunology portfolio,” said Kevin Ali, Organon’s CEO. “We believe that … upfront payment to Biogen, with Organon assuming the obligation to pay …
-
Organon Expands Portfolio With Biosimilar Tocilizumab-bavi for Arthritis and COVID-19
03 Apr 2025 21:03 GMT
… US. Under the agreement, Organon made an upfront payment … , chief executive officer of Organon, said in a news … for patients.
REFERENCES
1. Organon Acquires TOFIDENCE™ (tocilizumab-bavi), … #47;www.organon.com/news/organon-acquires-tofidence-tocilizumab …
-
Organon acquires Actemra biosimilar’s US rights from Biogen
02 Apr 2025 16:39 GMT
… arthritis and Covid-19.
Organon will make an upfront payment … biosimilar in the US market.
Organon CEO Kevin Ali stated, “ … , Macau and Hong Kong.
Organon’s portfolio includes medicines and … City, New Jersey, US.
Organon previously completed the acquisition of …
-
Organon/Henlius announce EMA validation for Perjeta biosimilar HLX11
02 Apr 2025 11:23 GMT
Organon and Shanghai Henlius Biotech have … treatment cohorts, the partners said.
Organon gained exclusive commercialisation rights to … of women,” said Kevin Ali, Organon’s chief executive officer, at …
-
Organon Expands Biosimilar Portfolio With Tofidence Acquisition
01 Apr 2025 22:04 GMT
… transferring U.S. rights to Organon.
Organon, an independent global healthcare company … upfront payment to Biogen, with Organon assuming obligations for tiered royalty … , Skyclarys, and Zurzuvae.
We believe Organon’s expertise in biosimilars commercialization …
-
Organon Lets Go of 93 Employees in New Jersey in Continuing Workforce Cuts
01 Apr 2025 15:20 GMT
… to optimize internal operations, Organon will lay off 93 … cholesterol-lowering drug Atozet. Organon stated in its SEC filing … its February press release, Organon shared that its fourth-quarter … payment to Biogen, with Organon paying tiered royalties based …
-
The Economics of Biosimilars
04 Apr 2025 11:51 GMT
… Medical Center and spokesperson for Organon to learn more about the … why I am collaborating with Organon, a company with a commitment …
-
Prolia® / Xgeva® Biosimilar Updates: Alvotech / Dr. Reddy’s AVT03 aBLA Acceptance, Fresenius Kabi’s Conexxence™ / Bomyntra™ FDA-Approval
03 Apr 2025 23:07 GMT
… , including Teva’s TVB-009P, Organon / Shanghai Henlius Biotech’s …
-
Community Medicine and Homoeopathy: A Holistic Approach to Public Health
03 Apr 2025 18:38 GMT
… the principles outlined in the Organon of Medicine, where Hahnemann emphasizes … . 2012;(12):CD001957.
Hahnemann S. Organon of Medicine. 6th ed. New …
-
WorkPride returns this June as workplace inclusivity becomes increasingly urgent
03 Apr 2025 16:32 GMT
… the event’s sponsors is Organon Pride Network. David Burton, their …